Skip to main content

TENAX THERAPEUTICS, INC. insider trading

TENXNASDAQ
$1.96-0.02 (-1.01%)as of Oct 5, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (-74.4%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • DIDellora Investments LP10% Owner0.9381%of company
  • DDDeclan DooganDirector0.1477%of company
  • CTChristopher Thomas GiordanoCEO0.0593%of company
  • TRThomas R. Staab IIChief Financial Officer0.0419%of company
  • SRStuart RichChief Medical Officer0.0338%of company
  • TMThomas McGauleyInterim CFO0.0214%of company
  • MHMichael H. DavidsonDirector0.0077%of company
  • JSJune Sherie AlmenoffDirector0.0053%of company
  • GTGerald T. ProehlDirector0.0045%of company
  • ACADAR1 Capital Management, LLC10% OwnerNot reportedof company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
TENXDeclan DooganDirectorOpen market purchase$102K+2330.7%$1.92$102KSep 16, 2026Sep 17, 2026
TENXChristopher Thomas GiordanoCEOOpen market purchase$8.84K+28.0%$1.82$8.84KSep 15, 2026Sep 15, 2026
TENXChristopher Thomas GiordanoCEOOpen market purchase$11.3K+53.0%$1.88$11.3KSep 11, 2026Sep 15, 2026
TENXThomas R. Staab IIChief Financial OfficerOpen market purchase$11K+56.8%$1.94$11KSep 11, 2026Sep 15, 2026
TENXADAR1 Capital Management, LLC10% OwnerOpen market purchase$1.6M+16.0%$1.78$1.6MSep 3, 2026Sep 8, 2026
TENXADAR1 Capital Management, LLC10% OwnerOpen market purchase$338K+3.5%$1.80$338KSep 2, 2026Sep 2, 2026
TENXADAR1 Capital Management, LLC10% OwnerOpen market purchase$322K+3.4%$1.80$322KSep 1, 2026Sep 2, 2026
TENXADAR1 Capital Management, LLC10% OwnerOpen market purchase$723K+8.3%$1.79$723KAug 31, 2026Sep 2, 2026
TENXADAR1 Capital Management, LLC10% OwnerOpen market purchase$188K+2.3%$1.75$188KAug 24, 2026Aug 24, 2026
TENXADAR1 Capital Management, LLC10% OwnerOpen market purchase$1.27M+17.8%$1.77$1.27MAug 21, 2026Aug 24, 2026
TENXADAR1 Capital Management, LLC10% OwnerOpen market purchase$360K+5.3%$1.78$360KAug 20, 2026Aug 24, 2026
TENXStuart RichChief Medical OfficerOpen market purchase$25.6K+24.6%$10.22$25.6KDec 9, 2025Dec 10, 2025
TENXStuart RichChief Medical OfficerOpen market purchase$25.3K+24.6%$10.10$25.3KDec 8, 2025Dec 10, 2025
TENXStuart RichChief Medical OfficerOpen market purchase$23K+38.9%$9.20$23KDec 4, 2025Dec 5, 2025
TENXStuart RichChief Medical OfficerOpen market purchase$13.6K+20.2%$9.08$13.6KDec 3, 2025Dec 5, 2025
TENXStuart RichChief Medical OfficerOpen market purchase$9.01K+12.6%$9.01$9.01KDec 2, 2025Dec 5, 2025
TENXChristopher Thomas GiordanoCEOOpen market purchase$4.08K+26.0%$7.59$4.08KNov 20, 2025Nov 20, 2025
TENXChristopher Thomas GiordanoCEOOpen market purchase$3.42K+28.2%$7.51$3.42KNov 19, 2025Nov 20, 2025
TENXChristopher Thomas GiordanoCEOOpen market purchase$12.5KNot reported$7.75$12.5KNov 18, 2025Nov 20, 2025
TENXJune Sherie AlmenoffDirectorOpen market purchase$14.3K+2043.0%$7.52$14.3KNov 18, 2025Nov 20, 2025
TENXThomas McGauleyInterim CFOOpen market purchase$36.2K+166.7%$7.23$36.2KNov 17, 2025Nov 19, 2025
TENXThomas McGauleyInterim CFOOpen market purchase$7.35K+14.3%$7.35$7.35KNov 17, 2025Nov 19, 2025
TENXThomas McGauleyInterim CFOOpen market purchase$14.7K+33.3%$7.34$14.7KNov 17, 2025Nov 19, 2025
TENXJune Sherie AlmenoffDirectorOpen market purchase$665Not reported$7.15$665Nov 17, 2025Nov 20, 2025
End of history · 24 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.